Constellation Pharmaceuticals Inc: Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

(marketscreener.com) Translational data support the disease-modifying potential of pelabresibCentral pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib treatment observed across a wide range of myelofibrosis patient subgroups CAMBRIDGE, Mass., June 11, 2021 -- Constellation Pharmaceuticals,...https://www.marketscreener.com/quote/stock/CONSTELLATION-PHARMACEUTI-44979177/news/Constellation-Pharmaceuticals-Provides-an-Update-from-the-Ongoing-MANIFEST-Study-of-Pelabresib-35579918/?utm_medium=RSS&utm_content=20210611